0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Antibody > Rabbit PAb Antibody > CD44 Antibody (Antigen Affinity Purified)

CD44 Antibody (Antigen Affinity Purified) PDF Download

Catalog Size (Price) Quantity In Stock Operation Other Information
12211-RP02
  YES          

CD44 Antibody ( Antigen Affinity Purified ) Datasheet

  Order or Inquire for CD44 Antibody product Antibody
  Detection limit is 0.5 ng/lane in WB
  Detection limit is 0.00975 ng/well in ELISA
 

CD44 Antibody Product Information

Immunogen :

Recombinant Human CD44 protein (Catalog#12211-H08H)

Antibody Type : Rabbit Polyclonal Antibody ( Antibody Purification Platform )
Ig Type :

Rabbit IgG

Formulation : 0.2 μm filtered solution in PBS with 5% trehalose
Preparation :

Produced in rabbits immunized with purified, recombinant Human CD44 (rh CD44; Catalog#12211-H08H; P16070-1; Met 1-Pro 220). CD44 specific IgG was purified by Human CD44 affinity chromatography.

CD44 Antibody Usage Guide

Specificity :

Human CD44

Western blot : This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human CD44 in WB. Using a DAB detection system, the detection limit for Human CD44 is approximately 4 ng/lane under non-reducing conditions and 0.5 ng/lane under reducing conditions.
Direct ELISA : This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human CD44. The detection limit for Human CD44 is approximately 0.00975 ng/well.
Storage : This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

CD44 Antibody Related Products & Topics

Related Areas:

Immunology>>Cluster of Differentiation>>CD44

Proteins:

Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
CD44 Human CD44 Protein, Recombinant 12211-H08H

Antibodies:

Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human CD44 WB, ELISA CD44 Antibody (Antigen Affinity Purified) 12211-RP02
Human CD44 ELISA, IHC-P CD44 Antibody 12211-MM01
Human CD44 FCM CD44 Antibody ( FITC ) 12211-MM02-F
Human CD44 WB, ELISA CD44 Antibody 12211-MM10

CD44 Antibody Background

CD44, short for Cluster of Differentiation 44, is an adhesion molecule of the hyaluronate receptor family. It is expressed in a large number of mammalian cell types. The adhesive function of CD44, like other molecules involved in inducible adhesion, is tightly regulated. Post-translational modifications, isoform expression, aggregation state, and protein associations all can affect the ligand binding properties of CD44, and these can vary depending on the cell type and the activation state of the cell. The principal ligand of CD44 is hyaluronan, and CD44 is involved in the metabolism of this compound. Furthermore, an increasing quantity of evidence suggests that CD44 has various functions related to inflammatory disease. CD44 deficiency induces severe liver injury. CD44-hyaluronate mediates in lymphocyte T and monocyte adhesion to the endothelium, stimulates proinflammatory cytokine release from macrophages and participates in dedifferentiation phenotype of smooth muscle cells from contractile state to synthetic one. CD44 acts in atherosclerotic plaque destabilization and neointimal proliferation after percutaneous vascular interventions. CD44 participates in many stages of atherosclerosis. CD44 also is a cell membrane protein often overexpressed on tumor cells and, being both a cell-cell and cell-extracellular matrix adhesion protein, is well positioned to contribute to this process.

References

  1. Krettek A. et al.,2009, Cardiovasc Hematol Disord Drug Targets. 9 (4): 293-302.
  2. Johnson P. et al., 2000, Biochem Pharmacol. 59 (5): 455-65.
  3. Kimura K. et al., 2010, Curr Opin Drug Discov Devel. 13 (1): 96-103.
  4. Protasiewicz J. et al., 2005, Pol Merkur Lekarski. 19 (112): 559-62.
  5. Jothy S. 2003, Clin Exp Metastasis. 20 (3): 195-201.

 

CD44 related areas, pathways, and other information